In C2-GBM, the highest mutation frequencies were observed in TP53 (42%), EGFR (34%), PTEN (27%), TTN (22%), MUC16 (17%), and NF1 (7%) (Figure 1G). This evidence concerns the gene TP53 and glioblastoma.